Who said succession planning can’t work in the hedge fund industry? Just ask the folks at Renaissance Technologies, which has not missed a beat since its founder, Jim Simons, passed away last year.

Renaissance Technologies' 13F portfolio value increased from $66.5B to $67.6B, with the top five stakes in Palantir, United Therapeutics, Novo Nordisk, Apple, and VeriSign. Significant stake ...

Renaissance disclosed the information in its latest 13F filing for the three months ended December 31, 2024, published on Thursday. The fund picked up 4.66M shares in Intel (NASDAQ:INTC), even as ...